MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by extracellular deposition of aggregated beta-amyloid (Aβ) peptides, so-called Aβ plaques, and buildup of intracellular hyperphosphorylated tau, both triggering neurodegeneration (DeTure and Dickson, 2019).